MMP2 and acute coronary syndrome: Fundamentally, platelets from patients with acute coronary syndromes release matrix metalloproteinase-2 (MMP-2), a major source of glycocalyceal damage [52,53], while, in turn, MMP-2 induces further platelet activation.